Header Logo

Connection

Christopher Seder to Early Detection of Cancer

This is a "connection" page, showing publications Christopher Seder has written about Early Detection of Cancer.
Connection Strength

0.257
  1. Lung cancer screening is here to stay, but does it pay? J Thorac Cardiovasc Surg. 2018 01; 155(1):426-427.
    View in: PubMed
    Score: 0.137
  2. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
    View in: PubMed
    Score: 0.046
  3. Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
    View in: PubMed
    Score: 0.038
  4. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.